Issue 26
Get instant access to latest e-book

latest news


Mar 2017

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Allergan plc a leading global pharmaceutical company and Paratek Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry announced that two Phase trials of sarecycline for the treatment of moderate to severe acne met their week…


Mar 2017

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Bruno Farmaceutici S.p.A.

Orexigen Therapeutics Inc announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd and Bruno Farmaceutici SpA Bruno have executed a distributorship agreement for Mysimba naltrexone HCl bupropion HCl prolonged release in Italy Mysimba is approved by the European Medicines Agency for the management of…


Mar 2017

Perrigo Completes Divestiture Of Tysabri® Royalty Stream For Up To $2.85 Billion

Perrigo Company plc a leading global provider of Quality Affordable Healthcare Products today announced it has completed the divestiture of its rights to the royalty stream from global net sales of the multiple sclerosis drug Tysabri natalizumab to RPI Finance Trust an affiliate of Royalty…

press releases


Mar 2017

Xenetic Biosciences Provides Update on Patent Portfolio Development

Xenetic Biosciences Inc a clinicalstage biopharmaceutical company focused on the discovery research and development of nextgeneration biologic drugs and novel orphan oncology therapeutics today provided an update to the progress…


Mar 2017

EUSA Pharma and Apeiron Biologics Receive Positive CHMP Opinion for dinutuximab beta for the Treatment of High-risk neuroblastoma in Europe

EUSA Pharma EUSA a specialty pharmaceutical company with a focus on oncology and oncology supportive care and Apeiron Biologics today announced that the European Medicines Agencys EMA Committee for Medicinal…


Mar 2017

Plasticell signs stem cell research collaborations with leading Singapore academic institutions

Plasticell a developer of stem cell technologies and cellbased therapies has announced that it has signed agreements with the Agency for Science Technology and Research ASTAR and the Nanyang Technological…

Events


Mar 2017

2nd Annual PharmaCon China 2017

Informa business
Grand Hyatt Shanghai


Mar 2017

analytica Vietnam 2017

Messe Munchen Gmbh
I.C.E. International Center for Exhibition


  • 2

    Parenteral Preparations

    INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..

Knowledge Bank

  • Interviews

    Datwyler Pharma Packaging

    Senior Manager Global Scientific Affairs
    Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..

  • Articles

    Improving Biopharma Productivity through Optimal Bioreactor Operation

    Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is double that of conventional pharmaceutical products The growing demand for therapeutic proteins and increasing focus from regulatory bodies have confronted the industry with challenges of ensuring affordability delivery and consistent quality…

  • Techno Trends

    New Liquid Biopsy Chip Allows to Trap Cancer Cells Easily

    Worcester Polytechnic Institute WPI researchers have developed a new chip that traps and identifies metastatic cancer cells within a tiny amount of blood drawn from a cancer patient Liquid Biopsy technique helps to capture and identify tumour cells andor DNA This technology uses a simple mechanical method which is efficient in trapping cancer cells than the micro fluidic approach used…

Editorial Section

  • Strategy

    Generics in Switzerland

    The article talks about the Swiss Generics market the penetration rate of generics in Switzerland why generics are a safe and smarter choice manufactured to modern standards with affordable prices and the threat of government forcing generic companies to benchmark…

  • Research development

    Biologics and Biosimilars

    With the early generation of biologics starting to lose patent protection the field of biosimilars too has been gaining attention Biosimilars are the generic version of a biologic drug developed for launch post the patent expiry of the original drug…

  • Clinical Trails

    Patient Recruitment

    To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…

  • Expert Talk

    Biologics’ Drug Delivery Systems

    In this interview Peter Soelkner of Vetter discusses drug delivery trends for biologics and in particular prefilled syringes He offers insight into the advantages and challenges of this system for biologics important issues to consider…